Aethlon Medical, Inc. (AEMD | DoD: -17.68% | YTD: -78.91% | SmallCap: 6M)

• Profile: A medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases
• Stock Offering: Aethlon Medical Announces Pricing of $4.5 Million Public Offering (Full Text)

Bruker Corporation (BRKR | DoD: -11.68% | YTD: -49.98% | MidCap: 5.6B)

• Profile: Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions
• Stock Offering: Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock (Full Text)

Sotera Health Company (SHC | DoD: -1.11% | YTD: +17.33% | MidCap: 3.5B)

• Profile: Provides sterilization, lab testing, and advisory services for the healthcare industry
• Stock Offering: Sotera Health Announces Secondary Offering of Common Stock (Full Text)

Senseonics Holdings, Inc. (SENS | DoD: -0.22% | YTD: -4.46% | SmallCap: 400M)

• Profile: A medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes
• Acquisition: Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365 (Full Text)

Senseonics Holdings, Inc. (SENS | DoD: -0.22% | YTD: -4.46% | SmallCap: 400M)

• Profile: A medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes
• Acquisition: Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics (Full Text)

Daxor Corporation (DXR | DoD: +2.02% | YTD: +40.79% | SmallCap: 41M)

• Profile: The global leader in blood volume measurement technology
• Clinical: Daxor's Blood Volume Analysis Validated for COVID and Sepsis Patients in New Peer-Reviewed Pilot Study Published in the Journal of Critical Care (Full Text)

Guardant Health, Inc. (GH | DoD: -2.18% | YTD: +104.78% | MidCap: 5.7B)

• Profile: A leading precision oncology company
• Clinical: Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test (Full Text)

IceCure Medical Ltd (ICCM | DoD: -2.78% | YTD: -14.63% | SmallCap: 59M)

• Profile: Developer of a liquid nitrogen-based system for freezing and destroying benign and cancerous tumors in the breast, kidney, lung and other areas
• Clinical: IceCure's ProSense® Substantially Reduces Abdominal Wall Endometriosis Pain with High Procedural Efficacy (Full Text)

Myriad Genetics, Inc. (MYGN | DoD: -1.45% | YTD: -49.63% | SmallCap: 423M)

• Profile: A molecular diagnostic testing and precision medicine company, develops and provides molecular tests
• Clinical: New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression (Full Text)

Personalis, Inc. (PSNL | DoD: -1.64% | YTD: -23.29% | SmallCap: 427M)

• Profile: Develops, markets, and sells advanced cancer genomic tests and services
• Clinical: Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing (Full Text)

Tandem Diabetes Care, Inc. (TNDM | DoD: -3.36% | YTD: -65.54% | MidCap: 1.4B)

• Profile: A leading insulin delivery and diabetes technology company
• Regulatory: Tandem t:slim Mobile App Now Authorized by Health Canada for iPhone and Android Phones (Full Text)

Tenon Medical, Inc. (TNON | DoD: -3.28% | YTD: -45.12% | SmallCap: 8M)

• Profile: A company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders
• Clinical: Tenon(R) Medical Announces Second Peer-Reviewed Catamaran Mainsail(TM) Study Publication, Underscores Robust and Sustainable Clinical Outcomes Out to 12 Months (Full Text)

Elutia Inc. (ELUT | DoD: -8.08% | YTD: -41.47% | SmallCap: 75M)

• Profile: A commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction
• Product: Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange (Full Text)

Koninklijke Philips N.V. (PHG | DoD: +0.33% | YTD: +12.66% | MidCap: 21.1B)

• Profile: A leading health technology company focused on improving people‚Äôs health and well-being through meaningful innovation
• Product: Philips launches smart telemetry platform for cardiac monitoring that provides continuous, enterprise-wide connectivity beyond the bedside (Full Text)

NanoVibronix, Inc. (NAOV | DoD: +1.11% | YTD: -91.96% | SmallCap: 3M)

• Profile: Focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance
• Patent: NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology (Full Text)

Nuwellis, Inc. (NUWE | DoD: -2.48% | YTD: -90.23% | SmallCap: 4M)

• Profile: A medical technology company focused on fluid management solutions for patients with fluid overload
• Product: Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management (Full Text)

Owlet, Inc. (OWLT | DoD: -3.58% | YTD: +71.36% | SmallCap: 101M)

• Profile: The pioneer of smart infant monitoring
• Product: Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa (Full Text)

Predictive Oncology Inc. (POAI | DoD: +3.71% | YTD: -1.37% | SmallCap: 8M)

• Profile: A leader in AI-driven drug discovery and biologics
• Collaboration: Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients (Full Text)

Quest Diagnostics Incorporated (DGX | DoD: -1.62% | YTD: +20.08% | MidCap: 19.3B)

• Profile: A leading provider of diagnostic information services
• Product: Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering (Full Text)

ResMed Inc. (RMD | DoD: -1.28% | YTD: +19.38% | LargeCap: 35.8B)

• Profile: A medical equipment company that primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions
• Product: Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority (Full Text)

STRATA Skin Sciences, Inc. (SSKN | DoD: -33.57% | YTD: -35.40% | SmallCap: 10M)

• Profile: A medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions
• Partnership: STRATA Skin Sciences' Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements (Full Text)

Smith & Nephew plc (SNN | DoD: +1.22% | YTD: +55.60% | MidCap: 12.7B)

• Profile: The global medical technology company
• Product: Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System (Full Text)

electroCore, Inc. (ECOR | DoD: -2.76% | YTD: -69.50% | SmallCap: 37M)

• Profile: A commercial-stage bioelectronic medicine and wellness company
• Partnership: electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress Relief (Full Text)

Anteris Technologies Global Corp. (AVR | DoD: -0.24% | YTD: -26.13% | SmallCap: 166M)

• Profile: A structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases
• Announcement: Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders (Full Text)

Autonomix Medical, Inc. (AMIX | DoD: -4.84% | YTD: -64.99% | SmallCap: 4M)

• Profile: A medical device company focused on advancing precision nerve-targeted treatments
• Event: Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment (Full Text)

Bone Biologics Corporation (BBLG | DoD: -2.36% | YTD: -64.86% | SmallCap: 3M)

• Profile: Focuses on bone regeneration in spinal fusion using the recombinant human protein
• Announcement: Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook (Full Text)

Pulse Biosciences, Inc. (PLSE | DoD: -2.77% | YTD: -15.06% | MidCap: 1.1B)

• Profile: Operates as a novel bioelectric medicine company
• Announcement: Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Full Text)

ICON Public Limited Company (ICLR | DoD: +1.22% | YTD: -15.34% | MidCap: 10.6B)

• Profile: A clinical research organization, provides outsourced development and commercialization services
• Leadership Update: ICON Announces CEO Transition (Full Text)

LivaNova PLC (LIVN | DoD: -0.58% | YTD: +21.31% | MidCap: 2.4B)

• Profile: A medical device company that develops devices used for cardiac surgery and neuromodulation
• Leadership Update: LivaNova Appoints Donald Zurbay as a New Director (Full Text)

Zentek Ltd. (ZTEK | DoD: -6.40% | YTD: -13.71% | SmallCap: 159M)

• Profile: Engages in the research and development of graphene and related nanomaterials
• Leadership Update: Zentek Announces Resignation of CEO - Greg Fenton to take New Strategic Leadership Role in U.S.-Based Venture (Full Text)

Zentek Ltd. (ZTEK | DoD: -6.40% | YTD: -13.71% | SmallCap: 159M)

• Profile: Engages in the research and development of graphene and related nanomaterials
• Leadership Update: Zentek Announces Changes to Board of Directors and Changes to Board Nominations for Upcoming Annual and Special Meeting of Shareholders (Full Text)